The IU School of Medicine, which attracted more than $300 million in research funding last year, hopes a new biomedical incubator will help it convert knowledge into innovative products and technology.
The top brass at Dow Chemical and DuPont will not go away empty handed after their companies merge and then split into three independent companies. The golden parachutes are spelled out in a new filing.
Under the deal, Franciscan was financially accountable for what it would spend on care for about 60,000 patients who had Anthem benefits provided by its employers or purchased individually. Would it work?